Cryoport, Inc. Files 8-K on Financials
Ticker: CYRX · Form: 8-K · Filed: Nov 7, 2024 · CIK: 1124524
| Field | Detail |
|---|---|
| Company | Cryoport, Inc. (CYRX) |
| Form Type | 8-K |
| Filed Date | Nov 7, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, sec-filing
TL;DR
Cryoport filed an 8-K on Nov 7th covering financials. Details to come.
AI Summary
On November 7, 2024, Cryoport, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as financial statements and exhibits. No specific financial figures or operational details were disclosed in the provided excerpt.
Why It Matters
This 8-K filing indicates Cryoport, Inc. is providing updates on its financial performance and condition to the SEC, which is important for investors to monitor the company's health.
Risk Assessment
Risk Level: low — The filing is a standard 8-K reporting financial information, not indicating any immediate or significant risks.
Key Players & Entities
- Cryoport, Inc. (company) — Registrant
- November 7, 2024 (date) — Date of Report
FAQ
What specific financial results are being reported by Cryoport, Inc. in this 8-K?
The provided excerpt of the 8-K filing indicates that it concerns 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits,' but does not detail the specific financial results within this section.
When was this 8-K report filed by Cryoport, Inc.?
The 8-K report was filed on November 7, 2024.
What is Cryoport, Inc.'s state of incorporation?
Cryoport, Inc. is incorporated in Nevada.
What is the principal executive office address for Cryoport, Inc.?
The principal executive offices are located at 112 Westwood Place, Suite 350, Brentwood, TN 37027.
What is the Commission File Number for Cryoport, Inc.'s SEC filings?
The Commission File Number for Cryoport, Inc. is 001-34632.
Filing Stats: 521 words · 2 min read · ~2 pages · Grade level 11.8 · Accepted 2024-11-07 16:31:16
Key Financial Figures
- $0.001 — e on which registered Common Stock, $0.001 par value CYRX The NASDAQ Stock Mar
Filing Documents
- tm2427809d1_8k.htm (8-K) — 27KB
- tm2427809d1_ex99-1.htm (EX-99.1) — 275KB
- image_009.jpg (GRAPHIC) — 5KB
- 0001104659-24-115344.txt ( ) — 503KB
- cyrx-20241107.xsd (EX-101.SCH) — 3KB
- cyrx-20241107_lab.xml (EX-101.LAB) — 33KB
- cyrx-20241107_pre.xml (EX-101.PRE) — 22KB
- tm2427809d1_8k_htm.xml (XML) — 4KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On November 7, 2024, Cryoport, Inc. (the "Company") issued a press release announcing its financial results for the third quarter ended September 30, 2024. A copy of the press release issued by the Company is attached hereto as Exhibit 99.1. The information, including the exhibit attached hereto, in this Current Report on Form 8-K shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as otherwise expressly stated in such filing.
Financial Statements and Exhibits
Financial Statements and Exhibits (d) Exhibits. The following material is filed as an exhibit to this Current Report on Form 8-K: Exhibit Number 99.1 Press Release dated November 7, 2024 issued by the Company. 104 Cover Page Interactive Data File (embedded within the inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: November 7, 2024 Cryoport, Inc. /s/ Robert Stefanovich Robert Stefanovich Chief Financial Officer